• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UBA6 的结构解释了它对泛素和 FAT10 的双重特异性。

Structures of UBA6 explain its dual specificity for ubiquitin and FAT10.

机构信息

Institute of Structural Biology, Rudolf Virchow Center for Integrative and Translational Bioimaging, University of Würzburg, Josef-Schneider-Straße 2, 97080, Würzburg, Germany.

Department of Molecular Oncology, Moffitt Cancer Center, Tampa, FL, 33612, USA.

出版信息

Nat Commun. 2022 Aug 15;13(1):4789. doi: 10.1038/s41467-022-32040-6.

DOI:10.1038/s41467-022-32040-6
PMID:35970836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9378703/
Abstract

The covalent modification of target proteins with ubiquitin or ubiquitin-like modifiers is initiated by E1 activating enzymes, which typically transfer a single modifier onto cognate conjugating enzymes. UBA6 is an unusual E1 since it activates two highly distinct modifiers, ubiquitin and FAT10. Here, we report crystal structures of UBA6 in complex with either ATP or FAT10. In the UBA6-FAT10 complex, the C-terminal domain of FAT10 binds to where ubiquitin resides in the UBA1-ubiquitin complex, however, a switch element ensures the alternate recruitment of either modifier. Simultaneously, the N-terminal domain of FAT10 interacts with the 3-helix bundle of UBA6. Site-directed mutagenesis identifies residues permitting the selective activation of either ubiquitin or FAT10. These results pave the way for studies investigating the activation of either modifier by UBA6 in physiological and pathophysiological settings.

摘要

泛素或泛素样修饰物与靶蛋白的共价修饰是由 E1 激活酶启动的,这些酶通常将单个修饰物转移到同源连接酶上。UBA6 是一种不寻常的 E1,因为它可以激活两种高度不同的修饰物,即泛素和 FAT10。在这里,我们报告了 UBA6 分别与 ATP 或 FAT10 形成复合物的晶体结构。在 UBA6-FAT10 复合物中,FAT10 的 C 末端结构域与 UBA1-泛素复合物中泛素的位置结合,但一个开关元件确保了两种修饰物的交替招募。同时,FAT10 的 N 末端结构域与 UBA6 的 3 螺旋束相互作用。定点突变鉴定出允许选择性激活泛素或 FAT10 的残基。这些结果为研究 UBA6 在生理和病理生理条件下激活两种修饰物的研究铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d923/9378703/6b8778696e86/41467_2022_32040_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d923/9378703/bbce6ec3a6de/41467_2022_32040_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d923/9378703/09a9e6efb5d4/41467_2022_32040_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d923/9378703/a45fe0fe5b3f/41467_2022_32040_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d923/9378703/252f651c40e9/41467_2022_32040_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d923/9378703/3ed0846a6715/41467_2022_32040_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d923/9378703/6b8778696e86/41467_2022_32040_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d923/9378703/bbce6ec3a6de/41467_2022_32040_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d923/9378703/09a9e6efb5d4/41467_2022_32040_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d923/9378703/a45fe0fe5b3f/41467_2022_32040_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d923/9378703/252f651c40e9/41467_2022_32040_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d923/9378703/3ed0846a6715/41467_2022_32040_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d923/9378703/6b8778696e86/41467_2022_32040_Fig6_HTML.jpg

相似文献

1
Structures of UBA6 explain its dual specificity for ubiquitin and FAT10.UBA6 的结构解释了它对泛素和 FAT10 的双重特异性。
Nat Commun. 2022 Aug 15;13(1):4789. doi: 10.1038/s41467-022-32040-6.
2
Mechanistic studies on activation of ubiquitin and di-ubiquitin-like protein, FAT10, by ubiquitin-like modifier activating enzyme 6, Uba6.泛素和二泛素样蛋白 FAT10 的激活机制研究,由泛素样修饰酶激活酶 6(Uba6)。
J Biol Chem. 2012 May 4;287(19):15512-22. doi: 10.1074/jbc.M111.336198. Epub 2012 Mar 15.
3
UBA6 and Its Bispecific Pathways for Ubiquitin and FAT10.UBA6 及其泛素和 FAT10 的双特异性途径。
Int J Mol Sci. 2019 May 7;20(9):2250. doi: 10.3390/ijms20092250.
4
Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.泛素激活酶UBE1与类泛素修饰因子FAT10的缀合作用将其靶向蛋白酶体降解。
PLoS One. 2015 Mar 13;10(3):e0120329. doi: 10.1371/journal.pone.0120329. eCollection 2015.
5
FAT10 : Activated by UBA6 and Functioning in Protein Degradation.FAT10:由UBA6激活并在蛋白质降解中发挥作用。
Subcell Biochem. 2010;54:238-46. doi: 10.1007/978-1-4419-6676-6_19.
6
Crystal structures reveal catalytic and regulatory mechanisms of the dual-specificity ubiquitin/FAT10 E1 enzyme Uba6.晶体结构揭示了双特异性泛素/FAT10 E1 酶 Uba6 的催化和调节机制。
Nat Commun. 2022 Aug 19;13(1):4880. doi: 10.1038/s41467-022-32613-5.
7
Structure of UBE2Z Enzyme Provides Functional Insight into Specificity in the FAT10 Protein Conjugation Machinery.UBE2Z酶的结构为FAT10蛋白缀合机制中的特异性提供了功能见解。
J Biol Chem. 2016 Jan 8;291(2):630-9. doi: 10.1074/jbc.M115.671545. Epub 2015 Nov 10.
8
The ubiquitin-like modifier FAT10 interferes with SUMO activation.泛素样修饰物 FAT10 干扰 SUMO 的激活。
Nat Commun. 2019 Oct 1;10(1):4452. doi: 10.1038/s41467-019-12430-z.
9
LMO2 blocks the UBA6-USE1 interaction and downstream FAT10ylation by targeting the ubiquitin fold domain of UBA6.LMO2通过靶向UBA6的泛素折叠结构域来阻断UBA6-USE1相互作用及下游的FAT10ylation。
Biochem Biophys Res Commun. 2016 Sep 23;478(3):1442-8. doi: 10.1016/j.bbrc.2016.08.143. Epub 2016 Aug 26.
10
The ubiquitin-like modifier FAT10 covalently modifies HUWE1 and strengthens the interaction of AMBRA1 and HUWE1.泛素样修饰物 FAT10 共价修饰 HUWE1 并增强 AMBRA1 和 HUWE1 的相互作用。
PLoS One. 2023 Aug 14;18(8):e0290002. doi: 10.1371/journal.pone.0290002. eCollection 2023.

引用本文的文献

1
The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentation.类泛素修饰因子FAT10对MHC-I抗原呈递并非必不可少。
Front Immunol. 2025 Aug 1;16:1636951. doi: 10.3389/fimmu.2025.1636951. eCollection 2025.
2
Molecular Choreography of E1 Enzymes in Ubiquitin-like Protein Cascades: New Insights into Dynamics and Specificity.泛素样蛋白级联反应中E1酶的分子编排:动力学与特异性的新见解
J Biol Chem. 2025 Jun 24:110415. doi: 10.1016/j.jbc.2025.110415.
3
Multi-omics analysis identifies UBA family as potential pan-cancer biomarkers for tumor prognosis and immune microenvironment infiltration.

本文引用的文献

1
Parkin is an E3 ligase for the ubiquitin-like modifier FAT10, which inhibits Parkin activation and mitophagy.Parkin 是一种 E3 连接酶,可连接泛素样修饰物 FAT10,抑制 Parkin 的激活和线粒体自噬。
Cell Rep. 2021 Mar 16;34(11):108857. doi: 10.1016/j.celrep.2021.108857.
2
Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix.利用 X 射线、中子和电子进行高分子结构测定: Phenix 的最新进展。
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877. doi: 10.1107/S2059798319011471. Epub 2019 Oct 2.
3
Crystal structure of a human ubiquitin E1-ubiquitin complex reveals conserved functional elements essential for activity.
多组学分析确定泛素相关蛋白家族为肿瘤预后和免疫微环境浸润的潜在泛癌生物标志物。
Front Immunol. 2025 Feb 17;16:1510503. doi: 10.3389/fimmu.2025.1510503. eCollection 2025.
4
Phosphorylated FAT10 Is More Efficiently Conjugated to Substrates, Does Not Bind to NUB1L, and Does Not Alter Degradation by the Proteasome.磷酸化的FAT10与底物的缀合效率更高,不与NUB1L结合,也不改变蛋白酶体介导的降解。
Biomedicines. 2024 Dec 9;12(12):2795. doi: 10.3390/biomedicines12122795.
5
Plasticity of the proteasome-targeting signal Fat10 enhances substrate degradation.蛋白酶体靶向信号 Fat10 的可塑性增强了底物降解。
Elife. 2024 Jul 10;13:e91122. doi: 10.7554/eLife.91122.
6
Prognostic significance of FAT10 expression in malignant tumors: a systematic review and meta-analysis.FAT10 表达在恶性肿瘤中的预后意义:系统评价和荟萃分析。
Future Oncol. 2024;20(21):1505-1514. doi: 10.1080/14796694.2024.2357531. Epub 2024 Jun 12.
7
Cytokines-activated nuclear IKKα-FAT10 pathway induces breast cancer tamoxifen-resistance.细胞因子激活的核 IKKα-FAT10 通路诱导乳腺癌对他莫昔芬耐药。
Sci China Life Sci. 2024 Jul;67(7):1413-1426. doi: 10.1007/s11427-023-2460-0. Epub 2024 Apr 1.
8
Disease-associated polyalanine expansion mutations impair UBA6-dependent ubiquitination.疾病相关多聚丙氨酸扩展突变会损害 UBA6 依赖性泛素化。
EMBO J. 2024 Jan;43(2):250-276. doi: 10.1038/s44318-023-00018-9. Epub 2024 Jan 2.
9
Insights into the ISG15 transfer cascade by the UBE1L activating enzyme.UBE1L 激活酶对 ISG15 转移级联的深入了解。
Nat Commun. 2023 Dec 2;14(1):7970. doi: 10.1038/s41467-023-43711-3.
10
Hepatocyte Deubiquitinating Enzyme OTUD5 Deficiency is a Key Aggravator for Metabolic Dysfunction-Associated Steatohepatitis by Disturbing Mitochondrial Homeostasis.肝细胞去泛素化酶 OTUD5 缺乏通过扰乱线粒体稳态是代谢功能障碍相关脂肪性肝炎的关键加重因素。
Cell Mol Gastroenterol Hepatol. 2024;17(3):399-421. doi: 10.1016/j.jcmgh.2023.11.014. Epub 2023 Nov 29.
人泛素 E1-泛素复合物的晶体结构揭示了活性所必需的保守功能元件。
J Biol Chem. 2018 Nov 23;293(47):18337-18352. doi: 10.1074/jbc.RA118.003975. Epub 2018 Oct 2.
4
The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation.泛素样修饰物 FAT10 的结构揭示了一种用于蛋白酶体降解的替代靶向机制。
Nat Commun. 2018 Aug 20;9(1):3321. doi: 10.1038/s41467-018-05776-3.
5
Human Leukocyte Antigen F Locus Adjacent Transcript 10 Overexpression Disturbs WISP1 Protein and mRNA Expression to Promote Hepatocellular Carcinoma Progression.人类白细胞抗原 F 座相邻转录本 10 过表达扰乱 WISP1 蛋白和 mRNA 表达,促进肝癌进展。
Hepatology. 2018 Dec;68(6):2268-2284. doi: 10.1002/hep.30105. Epub 2018 Nov 8.
6
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment.用于癌症治疗的泛素激活酶小分子抑制剂。
Nat Med. 2018 Feb;24(2):186-193. doi: 10.1038/nm.4474. Epub 2018 Jan 15.
7
Dissecting the Specificity of Adenosyl Sulfamate Inhibitors Targeting the Ubiquitin-Activating Enzyme.剖析靶向泛素激活酶的氨基磺酸腺苷抑制剂的特异性
Structure. 2017 Jul 5;25(7):1120-1129.e3. doi: 10.1016/j.str.2017.05.001. Epub 2017 Jun 1.
8
S. pombe Uba1-Ubc15 Structure Reveals a Novel Regulatory Mechanism of Ubiquitin E2 Activity.粟酒裂殖酵母Uba1-Ubc15结构揭示了泛素E2活性的一种新调控机制。
Mol Cell. 2017 Feb 16;65(4):699-714.e6. doi: 10.1016/j.molcel.2017.01.008. Epub 2017 Feb 2.
9
Structure of UBE2Z Enzyme Provides Functional Insight into Specificity in the FAT10 Protein Conjugation Machinery.UBE2Z酶的结构为FAT10蛋白缀合机制中的特异性提供了功能见解。
J Biol Chem. 2016 Jan 8;291(2):630-9. doi: 10.1074/jbc.M115.671545. Epub 2015 Nov 10.
10
Arc: building a bridge from viruses to memory.Arc:搭建从病毒到记忆的桥梁。
Biochem J. 2015 Jul 1;469(1):e1-3. doi: 10.1042/BJ20150487.